Head Office 4th Floor 135 West Street Sandown 2196 PO Box 55132 Northlands 2116 South Africa Tel +27 11 883 0205/6/7 Fax +27 11 784 2818 Email us here   Thumbnail Sketch of South Africa Why Clinical Trials in South Africa? Thumbnail Sketch of South Africa Regulatory Process for Trials in South Africa Population   47.9 million (2007) broad pharmacogenetic mix of race groups     (80% African, 9.6% White, 8.9% Coloured, 2.5% Indian/Asian) KwaZulu-Natal has the largest population with 21% and Gauteng 20% Female 51% and Male 49% Large number of accessible treatment-naïve patients Massive potential for HIV treatment and vaccine studies 264 423 patients on antiretroviral therapy at state clinics in March 2007 600 000 expected public sector patients on antiretroviral therapy by March 2010 Trial Experience:   Competent and experienced investigators are widely distributed throughout public and private sectors Public Sector   >20 academic and 8 psychiatric hospitals (>34 000 beds) >300 1º and 2º care hospitals and out-patient clinics Large number of treatment-naïve patients Young population – 44% aged < 20 yrs Private Sector   Approx 18% (8 million) of population have private medical aid State-of-Art diagnostic equipment and high-care facilities High academic/private crossover Largest private network operates > 140 clinics and hospitals Research-experienced mining and military hospitals HOME LEGAL NOTICES CONTACT US SITE MAP